Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism

• Auteurs principaux: Linjie Pan (Auteur), Zhanchi Xu (Auteur), Min Wen (Auteur), Minghui Li (Auteur), Dongxin Lyu (Auteur), Haiming Xiao (Auteur), Zhuoming Li (Auteur), Junhui Xiao (Auteur), Yuanyuan Cheng (Auteur), Heqing Huang (Auteur)
• Format: Livre
• Publié: BMC, 2024-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background Heart failure (HF) is characterized by a disorder of cardiomyocyte energy metabolism. Xinbao Pill (XBW), a traditional Chinese medicine formulation integrating "Liushen Pill" and "Shenfu Decoction," has been approved by China Food and Drug Administration for t...